227 related articles for article (PubMed ID: 19471255)
1. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease.
Márquez A; Orozco G; Martínez A; Palomino-Morales R; Fernández-Arquero M; Mendoza JL; Taxonera C; Díaz-Rubio M; Gómez-García M; Nieto A; López-Nevot MA; de la Concha EG; Martín J; Urcelay E
Am J Gastroenterol; 2009 Aug; 104(8):1968-75. PubMed ID: 19471255
[TBL] [Abstract][Full Text] [Related]
2. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
[TBL] [Abstract][Full Text] [Related]
3. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
4. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
5. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
6. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
7. STAT4 gene influences genetic predisposition to ulcerative colitis but not Crohn's disease in the Spanish population: a replication study.
Diaz-Gallo LM; Palomino-Morales RJ; Gómez-García M; Cardeña C; Rodrigo L; Nieto A; Alcain G; Cueto I; López-Nevot MA; Martin J
Hum Immunol; 2010 May; 71(5):515-9. PubMed ID: 20153791
[TBL] [Abstract][Full Text] [Related]
8. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
[TBL] [Abstract][Full Text] [Related]
9. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
[TBL] [Abstract][Full Text] [Related]
10. Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families.
Adamovic S; Amundsen SS; Lie BA; Gudjónsdóttir AH; Ascher H; Ek J; van Heel DA; Nilsson S; Sollid LM; Torinsson Naluai A
Genes Immun; 2008 Jun; 9(4):364-7. PubMed ID: 18418394
[TBL] [Abstract][Full Text] [Related]
11. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
Haas SL; Andreas Koch W; Schreiber S; Reinhard I; Koyama N; Singer MV; Böcker U
Scand J Gastroenterol; 2005 Dec; 40(12):1438-43. PubMed ID: 16316892
[TBL] [Abstract][Full Text] [Related]
12. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
13. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
[TBL] [Abstract][Full Text] [Related]
14. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
Dring MM; Goulding CA; Trimble VI; Keegan D; Ryan AW; Brophy KM; Smyth CM; Keeling PW; O'Donoghue D; O'Sullivan M; O'Morain C; Mahmud N; Wikström AC; Kelleher D; McManus R
Gastroenterology; 2006 Feb; 130(2):341-8; quiz 592. PubMed ID: 16472590
[TBL] [Abstract][Full Text] [Related]
15. Study of polymorphisms in 4q27, 10p15, and 22q13 regions in autoantibodies stratified type 1 diabetes patients.
Espino-Paisán L; De La Calle H; Fernández-Arquero M; Figueredo MA; De La Concha EG; Urcelay E; Santiago JL
Autoimmunity; 2011 Dec; 44(8):624-30. PubMed ID: 21875375
[TBL] [Abstract][Full Text] [Related]
16. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
[TBL] [Abstract][Full Text] [Related]
17. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility.
Márquez A; Cénit MC; Núñez C; Mendoza JL; Taxonera C; Díaz-Rubio M; Bartolomé M; Arroyo R; Fernández-Arquero M; de la Concha EG; Urcelay E
Genes Immun; 2009 Oct; 10(7):631-5. PubMed ID: 19657358
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis.
Festen EA; Goyette P; Scott R; Annese V; Zhernakova A; Lian J; Lefèbvre C; Brant SR; Cho JH; Silverberg MS; Taylor KD; de Jong DJ; Stokkers PC; Mcgovern D; Palmieri O; Achkar JP; Xavier RJ; Daly MJ; Duerr RH; Wijmenga C; Weersma RK; Rioux JD
Gut; 2009 Jun; 58(6):799-804. PubMed ID: 19201773
[TBL] [Abstract][Full Text] [Related]
19. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698
[TBL] [Abstract][Full Text] [Related]
20. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
